BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Gh Research plc

Headquarters: Dublin, Ireland
Year Founded: 2018
Status: Public
Industry Sector: HealthTechnology
CEO: Villy Valcheva, MD
Number Of Employees: 50
Enterprise Value: $215,496,998
PE Ratio: -12.15
Exchange/Ticker 1: NASDAQ:GHRS
Exchange/Ticker 2: N/A
Latest Market Cap: $564,455,680

BioCentury | Feb 7, 2025
Finance

Strong demand for Sionna latest good sign for IPOs: Public Equity Report

Vertex competitor posts a first-day gain after an upsized offering; plus financings for Gh Research and Tectonic
BioCentury | Feb 6, 2025
Product Development

Cardiometabolic wins among highlights in BioCentury’s latest Clinical Report

Plus readouts from Allakos, Leap, Cargo and more
BioCentury | Nov 8, 2022
Emerging Company Profile

Lusaris: treating depression with a new version of an old psychotropic

RA Capital leads $60M series A for the company, which is using Catalent’s technology to deliver 5-MeO-DMT
BioCentury | Oct 21, 2021
Data Byte

Europe’s largest venture rounds of the year

Europe’s top 13 biotech venture financings this year have raked in a combined $2B
Items per page:
1 - 4 of 4
Help Center
Username
Request a Demo
Request Training
Ask a Question